Table 2 Association between possible Sarcopenia and Katz ADL score.

From: Association between possible sarcopenia, all-cause mortality, and adverse health outcomes in community-dwelling older adults in China

 

β (95% CI)

Follow-up interval

Unadjusted

Model 1a

Model 2b

Model 3c

0 years

-0.19 (-0.23, -0.15)

-0.16(-0.20, -0.12)

-0.16(-0.20, -0.12)

-0.15(-0.19, -0.11)

P < 0.001

P < 0.001

P < 0.001

P < 0.001

2 years

-0.19 (-0.23, -0.14)

-0.15(-0.20, -0.10)

-0.15(-0.20, -0.10)

-0.13(-0.18, -0.09)

P < 0.001

P < 0.001

P < 0.001

P < 0.001

4 years

-0.26 (-0.31, -0.20)

-0.22(-0.28, -0.16)

-0.22(-0.28, -0.16)

-0.21(-0.27, -0.15)

P < 0.001

P < 0.001

P < 0.001

P < 0.001

7 years

-0.25 (-0.31, -0.18)

-0.18(-0.25, -0.12)

-0.18(-0.25, -0.12)

-0.18(-0.24, -0.11)

P < 0.001

P < 0.001

P < 0.001

P < 0.001

9 years

-0.27 (-0.33, -0.20)

-0.19(-0.26, -0.12)

-0.19(-0.25, -0.12)

-0.17(-0.24, -0.10)

P < 0.001

P < 0.001

P < 0.001

P < 0.001

  1. ADL, activities of daily living; β, regression coefficient; CI, confidence interval.
  2. aModel 1 was adjusted for age and sex.
  3. bModel 2 was adjusted for age, sex, body mass index, smoking status, and drinking status.
  4. cModel 3 includes the adjustments in model 2 in addition to the adjustments for hypertension, diabetes, cancer, chronic lung diseases, heart disease, and stroke.
Back to article page